Trade Summary

2 days ago, HALKUFF DAWN, serving as Dir at Xeris Biopharma Holdings, Inc. (XERS), sold 20,000 shares at $6.09 per share, for a total transaction value of $121,886.00. Following this transaction, HALKUFF DAWN now holds 95,000 shares of XERS.

This sale represents a 17.39% decrease in HALKUFF DAWN's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 6:18 PM ET, 1 day after the trade was made.

Xeris Biopharma Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.